Strong YoY growth masks revenue claim overstatement, uneven quarterly execution
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Reaffirmed FY27 guidance despite Q1 miss; historically has narrowed PPaaS exposure; international traction emerging but small scale.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
NPST delivered 68% YoY growth on a strategically diversified platform (payments, RegTech, AI, international), but Q1 revenue was overstated in the call (claimed ₹61.42 Cr vs delivered ₹56.5 Cr) and sequential decline forced management to defend with 'look at yearly.' Guidance of 60–70% FY27 growth and 30% EBITDA margin is reaffirmed but relies on unquantified MDR upside and lumpy milestone-based revenue. International margins (35%) and RegTech PSU order validate long-term pivot, but execution risk is real.
₹56.5 Cr
Revenue · +68% YoY₹11.1 Cr
Reported PAT · +53.6% YoYFlat
Margins · vs guidance: OverstatedDid the claims hold up?
Revenue closed at INR 61.42 crore
OVERSTATEDDelivered ₹56.5 Cr; claim overstates by ~₹4.9 Cr (8.6%)
Year-on-year uptake 75% in revenue
OVERSTATEDDelivered 68% YoY growth; claim overstates by 7 percentage points
Net profit INR 11.4 crore
METDelivered ₹11.1 Cr; materially aligned
EBITDA grown by 66%
METConsistent with 68% revenue growth and 18% NPM delivered; credible
International revenue 10–12% of total
METConfirmed in Q&A; one deal closed in Q1, two in pipeline
PPaaS segment reduced to 5% of revenue
METStated as deliberate de-risking while awaiting MDR clarity; no contradiction
Earnings quality
What changed since the last call
PPaaS contribution de-risked to 5%
DowngradePreviously 90% of revenue base. Now contingent on MDR regulation clarity. Management waiting for RBI/NPCI guidance; 'not denying positive direction but won't project until mandate received.'
International business materialization
UpgradeIn Q1 secured first international order (telecom super-app deal); previously aspirational. Two more deals in pipeline. Currently 10–12% of revenue; targeting 50% by FY28–29.
RegTech elevated to separate vertical
UpgradeWas a product; now standalone unit with PSU bank order for AI-based risk intelligence. Subscription model for SMB banks planned. Previously part of payment ecosystem; now positioned as strategic pillar.
FY27 guidance reaffirmed but execution lumpy
Neutral60–70% growth guidance unchanged, but Q1 at 68% (low-end) and QoQ negative. Management clarifies: milestone-based revenue timing varies; evaluate on yearly basis, not quarterly.
The Q&A
Analysts pressed hard on three fronts: (1) QoQ decline vs YoY growth narrative—management deflected with 'look at yearly, not quarterly'; (2) MDR quantification—management repeatedly refused to project until receiving formal mandate from RBI/NPCI, citing 'personal experience' only; (3) inorganic strategy timing—management vague ('three opportunities zeroed down, conditions strict, Q2 too early for acquisitions'). Overall: management held firm on guidance but showed caution, not conviction.
QoQ guidance miss — Akshay, AK Investments
PartialChanged business model—PPaaS de-risked to 5%, now technology-led subscription. Compare YoY, not QoQ. 60–70% annual growth guidance unchanged; 30% EBITDA margin guidance unchanged.
MDR revenue impact — Akshay, AK Investments
PartialVery positive for ecosystem. UPI doing 23B transactions; 5–10% at MDR rates huge revenue. We build acquiring infrastructure. TSP (us) will benefit. Waiting for regulator/NPCI/bank guidance; not immediate but 'visible difference.'
International business margins — Nishant Joshi, Equisense Advisors
AnsweredCurrently 10–12% of consolidated revenue from international. Implementation cycle 4–9 months. One deal closed Q1, two more in pipeline. Will be in good bucket by end of Q2.
MDR beneficiary model — Ankit Kanodia, Zen Nivesh
AnsweredBoth. TSP: banks invest more, we get indirect revenue. Payment platform: direct per-transaction revenue from bank's MDR income share (not charged to merchants). Two business models, both accrue benefit.
RegTech competition — Suman, individual investor
AnsweredTraditional RegTech (EFRM, EWS) has decade-old competition. Our AI-based risk intelligence is new; 650M transactions processed, 98% accuracy, first-mover. Global market attraction confirmed. Should translate to top line next couple of quarters.
Guidance confidence — Preet Shah, Blue Star Capital
Partial68% YoY already achieved this quarter. Execution cycle and implementation milestones drive revenue. 60–70% guidance unchanged. International revenue achieved. EBITDA maintained. RegTech growing. All green flags.
FY29 revenue target — Deepak Poddar, Sapphire Capital Partners
AnsweredRoughly ₹850–900 Cr by FY29. International 50% of revenue (or more) by FY28–29, with 30–35% margin (domestic 15–20%). 35%+ company-wide EBITDA margin aspiration for FY28–29.
Inventory spike — Abhishek Kajal, individual investor
AnsweredTurnkey projects include hardware supply to banks for offline payment. Hardware milestone-based delivery; software/service spread out. Q1 had early hardware realization for ₹5 Cr project.
Organic vs inorganic growth — Ashish Soni, Family Office
AnsweredIt is organic growth only. Not inorganic.
IPO fund deployment — Hardik Gandhi, HPMG
PartialZeroed down on three opportunities across RegTech, AI solutions, payment infrastructure. Strict conditions. Deployment starts next two quarters, focused on product development, market expansion, new products.
Guidance
FY27 full year ₹320–340 Cr (60–70% growth from FY26 base)
MediumQ1 delivered ₹56.5 Cr at 68% YoY; full-year guidance implies ₹90 Cr average quarterly run rate. Lumpy milestone-based revenue; Q2 realization critical.
FY28–29 revenue ₹850–900 Cr (60–70% CAGR; implies ~₹1.1–1.3 Tr by FY30)
MediumContingent on international reaching 50% of mix (from 10–12% now), RegTech scaling, and MDR revival. Three inorganic targets identified but not deployed yet.
FY27 EBITDA margin: 30%
MediumQ1 EBITDA growth 66% YoY; margin flat QoQ. Management confident orders in Q2 will add higher-margin (RegTech, international) revenue.
FY28–29 company-wide EBITDA margin: 35%+
MediumDriven by international business (30–35% margins) reaching 50% of revenue. Domestic margins held at 15–20%. Blended uplift to 35%+ feasible but requires flawless international execution.
IPO fund deployment: ₹~40–60 Cr in next two quarters (H2 FY27)
LowManagement vague on targets. Identified three inorganic opportunities (RegTech, AI solutions, payment infra) but no specifics. Deployment spread over 2–3 years possible.
Risks the call surfaced
Regulatory dependency (MDR)
HighPPaaS segment (5% of revenue) contingent on MDR regulation clarity from RBI/NPCI. No formal guidance received yet. If delayed or unfavorable, upside deferred; impacts 60–70% growth guidance.
International execution risk
HighCurrently 10–12% of revenue. One deal closed in Q1; two in pipeline. Target 50% by FY28–29 (4–9 month implementation cycles). Limited proof of concept; heavy margin expansion assumption (30–35% vs 15–20% domestic).
Business model transformation
HighShifting from 90% PPaaS to diversified SaaS/RegTech/international. Q1 sequential decline (-10% QoQ) and revenue claim miss (₹61.42 claimed vs ₹56.5 delivered) suggest execution complexity. Guidance reaffirmed but visibility lumpy.
Regulatory risk (AI/cyber security)
MediumRBI released guidelines on AI security threats (June 2026). Potential for mandated AI-based compliance tools across banking sector. NPST positions RegTech/AI as opportunity but implementation timeline unclear; no formal RFP yet.
Inorganic execution risk
MediumIPO funds (~₹400 Cr) received December 2025; only 10–15% deployed by August 2026 (8 months). Three acquisition targets identified but no formal announcements; deployment timeline Q2 FY27 onwards (speculative).
Management
Score 6/10. Detailed on strategy and product roadmaps (RegTech, international, AI-driven org). Transparent on challenges (MDR awaiting clarity, business transformation lumpy). However, overstated Q1 revenue claim (₹61.42 vs ₹56.5 Cr) in opening; not revisited. Defensive on sequential decline. Met YoY 60–70% growth target (68% in Q1). Guided 15–20% QoQ sequential growth; missed heavily (down 10%). Reaffirmed full-year 60–70% and 30% EBITDA guidance post-miss. International deal closed (validates expansion); RegTech PSU order closed (validates diversification). Track record mixed.
1 · Q2–Q3 FY27
MDR on UPI regulation finalized; PPaaS segment revival expected if direct revenue share confirmed
2 · Q2–Q3 FY27
Two additional international deals (besides Q1 telecom super-app) expected to enter revenue realization phase
3 · H2 FY27
RegTech subscription model launch for mid-to-small banks; PSU order execution contributes margin uplift
International margins (35%) and RegTech PSU order validate long-term pivot, but execution risk is real.
Informational and educational content only. Not investment advice.